Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of Health Nationwide (Federal)
Deadline
2028-05-07
Region
Nationwide (Federal)
Funder type
Federal Government
For
Nonprofits & businesses
Sectors
Health & Human Services
About this program
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) — U.S. federal funding opportunity (PAR-25-374) from National Institutes of Health. See grants.gov for full eligibility and details.
Is this grant worth your time?
Create a free account and Happy Grants scores this program — and 2,000+ others — against your organization's profile in about a minute, with the reasons explained.
See your match score — freeRelated programs
Cartier Women's Initiative Awards
Cartier Women's Initiative
Applications open for Egypt Annual Program Statement (Egypt)
U.S. Department of State
2026-08-31RFAs: Unlocking Dataset Value for AI-Enabled Scientific Discovery (US)
U.S. National Science Foundation (NSF)
2026-11-04EcoConnexions From the Ground Up Program (US)
CN / America in Bloom
RollingRBC Foundation USA Community Investments
RBC Foundation USA
up to US$2,500,000 RollingPathfinder Grant (Exploration Fund Grant)
Explorers Club
US$2,500 to US$5,000 2026-08-31